DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr | ₹75 Cr | ₹-83 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-269 Cr |
Mar2023 | ₹-2,707 Cr |
Mar2022 | ₹-2,195 Cr |
Mar2021 | ₹75 Cr |
Mar2020 | ₹-83 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-269 Cr | Negative | |
Mar2023 | ₹-2,707 Cr | Negative | |
Mar2022 | ₹-2,195 Cr | Negative | |
Mar2021 | ₹75 Cr | Positive | |
Mar2020 | ₹-83 Cr | - |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹178,376.2 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,824.0 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
CIPLA | ₹122,929.0 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,502.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics | |
MANKIND PHARMA | ₹98,151.0 Cr | 0.7% | -6.7% | 10.3% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.3% |
10.7% |
49.3% |
SENSEX | 1.9% |
0.1% |
10.9% |
You may also like the below Video Courses